Agents with antialdosterone properties should be the preferred diuretics for reducing hypertension related atrial fibrillation.
Jolobe
Oscar M P
OM
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D004232:Diuretics / Q000627:therapeutic use*; D000077545:Eplerenone; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D013148:Spironolactone / Q000031:analogs & derivatives / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D000077786:Torsemide
D000959:Antihypertensive Agents; D004232:Diuretics; D013449:Sulfonamides; D013148:Spironolactone; D000077545:Eplerenone; D000077786:Torsemide